EMJ Neurology 9.2 2021

In this supplement text to EMJ Neurology, two key opinion leaders, Mark S Freedman and Lluís Ramió-Torrentà, discussed the current approaches and challenges in the assessment of disease activity and progression in relapsing-remitting multiple sclerosis (RRMS). The interviewees also provide their perspectives on this topic of disease activity and progression in patients with RRMS, including an overview of the measurement tools that can be utilised in clinical practice.